Given that IL-6 levels are elevated in SSc patients, this cytokine environment is thought to skew the Th17/Treg balance towards the Th17 subset, thereby exacerbating both fibrosis and inflammation in SSc [125]. This evidence concerns the gene IL6 and systemic sclerosis.